X0306 4 2014-10-27 0 0001488613 Foundation Medicine, Inc. FMI 0001585005 Kafka Steven J. 150 SECOND STREET C/O FOUNDATION MEDICINE, INC. CAMBRIDGE MA 02141 0 1 0 0 Chief Operating Officer Common Stock 2014-10-27 4 M 0 10000 4.16 A 14787 D Common Stock 2014-10-27 4 S 0 10000 25.3127 D 4787 D Stock Option (right to buy) 4.16 2014-10-27 4 M 0 10000 0.00 D 2023-03-07 Common Stock 10000 113000 D The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2014. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2014. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.59, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. This option was granted on March 7, 2013. Twenty-five percent vested on January 2, 2014 and an additional 6.25% vests each successive quarter thereafter until fully vested on January 2, 2017. Robert Hesslein, as Attorney-in-Fact for Steven J. Kafka 2014-10-29